Exploring the Application Efficacy of Artificial Intelligence (AI) Diagnostic Tools in Medical Imaging (MI) of Respiratory(R) Infectious (I) Disease (D)
Huashan Hospital
2,000 participants
Apr 1, 2022
INTERVENTIONAL
Conditions
Summary
The early identification and severe warning of acute respiratory infectious diseases are of paramount importance. Utilizing effective means to make correct diagnoses of the source of infection at an early stage is the premise of all effective measures. AI-MID is a research initiative that uses artificial intelligence tools to assist in the clinical medical imaging diagnosis of respiratory diseases, aiming to reduce the time doctors spend reviewing images, increase work efficiency, and enhance the sensitivity and specificity of pneumonia detection, thereby improving the detection rate of pneumonia at the grassroots level. This approach facilitates precise prevention, accurate diagnosis, and precise treatment.
Eligibility
Inclusion Criteria4
- 1-90 years old, gender not specified.
- Exhibits symptoms of respiratory tract infection
- Must have etiological examination results
- Must have imaging data;
Exclusion Criteria4
- Severe artifacts in medical images
- Clinical diagnosis indicates concurrent pulmonary edema
- Dual review results in unclear diagnosis or potential misdiagnosis
- Other situations that may cause difficulties in reading the films, or as determined by the researcher, the study participant is deemed unsuitable for enrollment.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In the AI interpretation group, using clinical information, imaging data, and corresponding etiological results of the study participants, an AI diagnostic tool is established to specifically recognize patients' chest medical imaging and construct corresponding diagnostic conclusions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06553911